# Clinical Study to Evaluate the Efficacy and Tolerability of an Anti-inflammatory/Antibiotic Treatment Following Ocular Cataract Extraction

> **NCT02973880** · PHASE3 · COMPLETED · sponsor: **SIFI SpA** · enrollment: 180 (actual)

## Conditions studied

- Cataract Extraction
- Cataract

## Interventions

- **DRUG:** NETILDEX™ ophthalmic gel
- **DRUG:** NETILDEX™ eye drops solution

## Key facts

- **NCT ID:** NCT02973880
- **Lead sponsor:** SIFI SpA
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-10-15
- **Primary completion:** 2018-12-01
- **Final completion:** 2018-12-30
- **Target enrollment:** 180 (ACTUAL)
- **Last updated:** 2019-01-14

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02973880

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02973880, "Clinical Study to Evaluate the Efficacy and Tolerability of an Anti-inflammatory/Antibiotic Treatment Following Ocular Cataract Extraction". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT02973880. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*